Curon Biopharma
About:
Curon Biopharma is a Healthcare company.
Website: http://www.curonbiopharma.com/
Top Investors: Boyu Capital, 6 Dimensions Capital, Temasek Holdings
Description:
Curon Biopharma is a developer of drugs intended designed for immuno-oncology therapies. The company's drugs consist of multiple class-leading cancer immunotherapeutic agents in the world that could address the shortcomings of current cancer treatment paradigm, enabling a physician to provide advanced cancer immunotherapies to their patients.
Total Funding Amount:
$150M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2018-01-01
Founders:
Paul Song
Number of Employees:
11-50
Last Funding Date:
2018-07-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai